RBC Capital analyst Ashish Sabadra initiated coverage of CME Group with a Sector Perform rating and $235 price target. CME has underperformed peers due to concerns about competitor exchange FMX gaining market share and the potential decline in interest rate futures trading volume due to the rate cut cycle, notes the analyst. While the firm believes competitive headwinds “appear manageable and reflected in the valuations” and that increased Treasury issuance should provide medium- to long-term secular tailwinds, it also believes the stock could be range-bound until there is a change in narrative and/or change in the capital allocation policy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group initiated with a Hold at TD Cowen
- Citi recommends overweight CME, underweight Cboe pair trade
- Buy/Sell: Wall Street’s top 10 stock calls this week
- CME Group to launch options on BCOM futures on September 23, pending review
- Citi opens ‘positive catalyst watch’ on CME into dividend announcement